Get the Stockscreener App
68.64
0.36%
-0.25
After Hours:
68.64
Henry Schein Inc stock is traded at $68.64, with a volume of 2.01M.
It is down -0.36% in the last 24 hours and up +3.75% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$68.89
Open:
$69.03
24h Volume:
2.01M
Relative Volume:
1.13
Market Cap:
$7.95B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
28.13
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
+5.11%
1M Performance:
+3.75%
6M Performance:
+0.94%
1Y Performance:
-6.54%
1-Day Range:
$68.27
$69.24
1-Week Range:
$62.60
$69.38
52-Week Range:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
68.64 | 7.95B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
693.46 | 88.78B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
283.00 | 56.59B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
148.22 | 35.69B | 222.29B | 1.56B | 2.44B | 6.41 |
|
OMI
Owens Minor Inc
|
7.01 | 580.18M | 10.42B | -38.77M | 323.54M | -0.51 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Henry Schein outlines 2025 growth targets amid strategic restructuring and stable market conditions - MSN
Henry Schein misses quarterly revenue estimates on weak demand for dental products - MSN
Henry Schein First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Dental Consumables Market Projected to Hit USD 70.55 Billion by 2032 Amid Rising Demand for Aesthetic and Restorative Dental Care – SNS Insider - GlobeNewswire Inc.
Henry Schein (HSIC) Maintains 'Outperform' Rating Despite Price Target Adjustment | HSIC Stock News - GuruFocus
Henry Schein Schedules May Investor Presentations - Dentistry Today
Barrington Research Adjusts Henry Schein Price Target to $86 From $90, Maintains Outperform Rating - marketscreener.com
Henry Schein (HSIC) Price Target Lowered by Wells Fargo Analyst - GuruFocus
Henry Schein (HSIC) Price Target Lowered by Wells Fargo Analyst | HSIC Stock News - GuruFocus
What 6 Analyst Ratings Have To Say About Henry Schein - Benzinga
These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results - Benzinga
Henry Schein, Inc. (NASDAQ:HSIC) Q1 2025 Earnings Call Transcript - Insider Monkey
Henry Schein (HSIC) Sees Price Target Cut Despite Strong Q1 Repo - GuruFocus
Henry Schein Positioned for Growth: Buy Rating Reaffirmed Amid Strategic Expansion and Board Expertise - TipRanks
Henry Schein to Participate in Upcoming Investor Conferences in May | HSIC Stock News - GuruFocus
Henry Schein Reports First Quarter 2025 Financial Results - Zenopa
Henry Schein to Participate in Upcoming Investor Conferences in May 2025 - BioSpace
Wells Fargo Adjusts Price Target for Henry Schein (HSIC) | HSIC Stock News - GuruFocus
Henry Schein Sets Bank of America and Stifel Conference Appearances: Key Dates for Healthcare Investors - Stock Titan
Henry Schein to Participate in Upcoming Investor Conferences in May - Bluefield Daily Telegraph
Henry Schein Inc (HSIC) Q1 2025 Earnings Call Highlights: Strategic Growth Amid Currency Challenges - Yahoo Finance
Henry Schein Inc (HSIC) Q1 2025 Earnings Call Highlights: Strate - GuruFocus
Earnings call transcript: Henry Schein Q1 2025 sees modest EPS beat, stock dips - Investing.com Canada
Henry Schein Reports Strong Q1 2025 Earnings - TipRanks
Henry Schein: Q1 Earnings Snapshot - MySA
Henry Schein’s Earnings Call: Balancing Growth and Challenges - TipRanks
Henry Schein Dental Merchandise Sales Up, Equipment Flat in Q1 2025 Reporting - Orthodontic Products
Henry Schein's Q1 2025 Earnings: What to Expect - MSN
Henry Schein discloses pay hikes for top leaders - Medical Design & Outsourcing
Compared to Estimates, Henry Schein (HSIC) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Henry Schein, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:HSIC) - Seeking Alpha
Henry Schein advances BOLD plan - HME News
Henry Schein Faces Dental Market Setback, But Holds Firm On Profit Forecasts - Finimize
Henry Schein Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings Summary: Henry Schein (HSIC) reports higher Q1 2025 profit - AlphaStreet
Henry Schein's Reports Mixed Bag Q1 Earnings, CEO Confident In Business Fundamentals - Benzinga
Henry Schein Q1 Earnings Top Estimates, Revenues Miss, Stock Falls - Yahoo Finance
S&P 500 Futures Drop in Premarket Trading; AngloGold Ashanti, Henry Schein Lead - Barron's
Henry Schein Q1 2025 slides: Modest earnings growth despite flat sales, guidance maintained - Investing.com
Henry Schein (HSIC) Q1 Earnings Beat Estimates - Yahoo Finance
Henry Schein Inc Reports Q1 2025 Earnings: GAAP EPS of $0.88 Mis - GuruFocus
Henry Schein's Fiscal Q1 Adjusted Earnings Rise, Revenue Flat; Maintains 2025 Guidance - marketscreener.com
Henry Schein, Inc. (HSIC) Announces Key Changes in Strategic Partnership and Board Appointment - GuruFocus
Henry Schein misses revenue estimates, maintains 2025 outlook, shares edge down - Investing.com Nigeria
Henry Schein Inc. Q1 Profit Increases, Beats Estimates - Nasdaq
(HSIC) Henry Schein Expects Full Year 2025 Adjusted EPS Range $4.80$4.94, vs. FactSet Est of $4.84 - marketscreener.com
Henry Schein Reports First Quarter 2025 Financial Results | HSIC Stock News - GuruFocus
Henry Schein (HSIC) Reports Q1 Revenue Below Expectations | HSIC Stock News - GuruFocus
Henry Schein (NASDAQ:HSIC) Reports Sales Below Analyst Estimates In Q1 Earnings - Yahoo Finance
Henry Schein earnings beat by $0.03, revenue fell short of estimates - Investing.com UK
BRIEF-Henry Schein Q1 Adjusted EPS USD 1.15 Vs. IBES Estimate USD 1.11 - TradingView
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
0.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):